NTHI NeOnc Technologies Holdings, Inc.
Company Analysis
Latest News
🟢 NeOnc Technologies Holdings is trading 6.4% up today — immediate catalyst unclear
NeOnc Technologies Holdings is trading 6.4% up at $4.99, after rising from the August 28 close of $4.69; the immediate catalyst is unclear. - No new...
🟢 NeOnc Technologies Holdings is trading 6.61% up in pre-market
NeOnc Technologies Holdings is trading 6.61% up in pre-market at $5.00, versus $4.69 at the August 28, 2026 close; no new company-specific announcement was...
🟢 NeOnc Technologies Holdings is trading 5% up today amid biotech-sector momentum
NeOnc Technologies Holdings is trading 5.39% up now at $4.94 after opening-market gains on August 25, 2026, with biotech-sector momentum the clearest...
🔴 NeOnc Technologies Holdings is trading 5.78% down in pre-market with no clear catalyst identified
NeOnc Technologies Holdings is trading 5.78% down at $4.42 in pre-market after falling from the August 24 close of $4.69, with no clear company-specific...
🔴 NeOnc Technologies Holdings is trading 5.5% down in after-hours trading with no clear catalyst identified
NeOnc Technologies Holdings is trading 5.5% down at $4.43 after-hours on August 24, 2026, with no clear company-specific announcement or late-breaking catalyst...
🟢 NeOnc Technologies Holdings is trading 7.27% up today
NeOnc Technologies Holdings is trading at $5.01 (+7.27%), though the immediate catalyst is unclear. - No clear August 24, 2026 company-specific announcement...
🔴 NeOnc Technologies Holdings is trading 11.23% down in pre-market — no clear company-specific catalyst identified
NeOnc Technologies Holdings is trading 11.23% down at $4.15 in pre-market, based on the provided pre-market quote, with no clear company-specific catalyst...
🔴 NeOnc Technologies Holdings is trading 6.16% down today after profit-taking and biotech weakness
NeOnc Technologies Holdings is trading 6.16% down at $4.34 after profit-taking and broader biotech weakness. - The biotech sector is down 2.47%, contributing...
🔴 NeOnc Technologies Holdings is trading 15.01% down today after rally following positive Phase 2a NEO100 results
NeOnc Technologies Holdings is trading 15.01% down now at $4.70 after a sharp multi-session rally. - The stock rose 31.46% on August 14, 16.35% on August 17,...
🔴 NeOnc Technologies Holdings is trading 9.3% down today after a sharp multi-session rally
NeOnc Technologies Holdings is trading 9.3% down now at $4.98 after a sharp multi-session rally. - The stock gained 31.46% on August 14, 16.35% on August 17,...
NeOnc's Brain Cancer Drug Beats Survival Benchmarks and the CEO Is Buying — But Can a Five-Person Company With Months of Cash Turn Promise Into Product?
Shares of NeOnc Technologies Holdings (NTHI) surged +10.8% to $5.44 on August 18, extending a rally that has nearly doubled the stock from its $3.01 52-week...
🟢 NeOnc Technologies Holdings is trading 10.79% up today after positive August 12 Phase 2a NEO100 results
NeOnc Technologies Holdings is trading at $5.44 (+10.79%) after extending its recent rally following positive August 12 Phase 2a NEO100 results. • CEO Amir...
🟢 NeOnc Technologies Holdings is trading 5.9% up today
NeOnc Technologies Holdings is trading 5.9% up at $5.20, extending a volatile advance after rising 16.35% on August 17 and 31.46% on August 14. - No new...
🟢 NeOnc Technologies Holdings is trading 14% up today
NeOnc Technologies Holdings is trading at $4.79, up 13.51% on August 17, 2026, while the immediate catalyst remains unclear. - The stock rose 31.46% on August...
🟢 NeOnc Technologies Holdings is trading 6.16% up today with no new company-specific catalyst identified
NeOnc Technologies Holdings is trading $4.48, up 6.16% after a volatile run, with no new August 17 company-specific catalyst directly explaining the move. -...
🔴 NeOnc Technologies Holdings is trading 6.32% down today after positive Phase 2a NEO100 results
NeOnc Technologies Holdings is trading at $3.95, down -6.32%, amid substantial recent volatility following positive Phase 2a NEO100 results. • The stock...
NeOnc Technologies Holdings, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 17, 2026
NeOnc Technologies is expected to report a Q2 2026 consensus loss of $0.16 per share on zero revenue, with the stock currently trading at $4.22 against an...
🟢 NeOnc Technologies Holdings is trading 20% up today after positive Phase 2a NEO100 results
NeOnc Technologies Holdings is trading sharply higher on August 14, 2026, after positive Phase 2a results for intranasal NEO100 in recurrent IDH1-mutant...
NeOnc Technologies Reports Positive Phase 2a Trial Results for Brain Cancer Drug NEO100
NeOnc Technologies Holdings announced positive top-line results from the Phase 2a portion of its NEO100-01 clinical trial for patients with recurrent IDH1...
🔴 NeOnc Technologies Holdings is trading 6.36% down today amid volatile post-catalyst trading
NeOnc Technologies Holdings is trading 6.36% down at $3.24, despite positive Phase 2a NEO100 results released August 12, 2026. - The study met its primary...